tci Part B Insider - 2005 Issue 10

MEDICATIONS: Neurologists Face Challenge Covering Cost Of Apokyn Injections

3 options for easing the cost of tricky first dose Sometimes when a new miracle drug hits the market, you may need a miracle to obtain payment for it. A case in point is the drug Apomorphine, sold under the name Apokyn by Mylan Bertek Pharmaceuticals. Although Apokyn has been around for years, the Food and Drug Administration just approved the drug last year for patients immobilized by Parkinson's disease. Many Medicare carriers won't cover Apokyn because the patient can self-administer it. One carrier, Wisconsin Physicians Insurance Service Corp., announced it would cover Apokyn incident-to a physician's services . With...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.